GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 117 filers reported holding GENOMIC HEALTH INC in Q3 2015. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,056,000 | +51.7% | 15,575 | +30.1% | 0.00% | 0.0% |
| Q2 2019 | $696,000 | -38.1% | 11,972 | -25.4% | 0.00% | -50.0% |
| Q1 2019 | $1,125,000 | +22.3% | 16,058 | +12.5% | 0.00% | 0.0% |
| Q4 2018 | $920,000 | -13.4% | 14,276 | -5.6% | 0.00% | 0.0% |
| Q3 2018 | $1,062,000 | +40.8% | 15,120 | +1.1% | 0.00% | +100.0% |
| Q2 2018 | $754,000 | +67.9% | 14,962 | +4.4% | 0.00% | 0.0% |
| Q1 2018 | $449,000 | -5.5% | 14,338 | +3.3% | 0.00% | 0.0% |
| Q4 2017 | $475,000 | +12.8% | 13,877 | +5.8% | 0.00% | 0.0% |
| Q3 2017 | $421,000 | +1.7% | 13,113 | +3.0% | 0.00% | 0.0% |
| Q2 2017 | $414,000 | -17.7% | 12,734 | -46.4% | 0.00% | -50.0% |
| Q3 2015 | $503,000 | -20.3% | 23,760 | +4.6% | 0.00% | 0.0% |
| Q2 2015 | $631,000 | +24.5% | 22,710 | +36.8% | 0.00% | 0.0% |
| Q1 2015 | $507,000 | – | 16,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 11,744,010 | $756,432,000 | 6.19% |
| EMORY UNIVERSITY | 30,319 | $1,953,000 | 1.54% |
| Copper Rock Capital Partners, LLC | 292,596 | $18,630,000 | 1.46% |
| DE BURLO GROUP INC | 73,600 | $4,740,000 | 1.06% |
| Eversept Partners, LP | 23,866 | $1,537,209 | 0.83% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 165,310 | $10,648,000 | 0.83% |
| Aurora Investment Counsel | 20,916 | $1,347,000 | 0.73% |
| Texas Children's | 8,035 | $518,000 | 0.72% |
| Capital Impact Advisors, LLC | 24,665 | $1,570,000 | 0.67% |
| Granahan Investment Management | 130,650 | $8,415,000 | 0.60% |